Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=91f31f28-a005-4d67-b042-d8ce82c31d8e&Preview=1
Date 5/8/2012
Company Name Retrophin
Mailing Address 330 Madison Avenue 6th Floor New York, NY 10017
Company Description Retrophin, LLC is a privately-held New York-based, biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases.
Proceeds Purposes The company intends to invest the proceeds from the Series A financing to advance its pipeline of novel rare-disease drug candidates, including a proof-of-concept study of RE-021 (a dual acting receptor antagonist of Angiotensin and Endothelin receptors) in Focal Segmental Glomerulosclerosis (FSGS) scheduled to begin enrolling patients during the second quarter of this year.